The role of proteasome inhibitors in multiple myeloma
The biases of using bone marrow biopsies for multiple myeloma
The epigenetics of multiple myeloma and the rationale for HDAC inhibitors
Multiple myeloma: consensuses and controversies
Faith Davies et al.
What is the best treatment regimen for MM?